Hepatectomy

• 

  Subject Areas on Research

  • A Machine-Based Approach to Preoperatively Identify Patients with the Most and Least Benefit Associated with Resection for Intrahepatic Cholangiocarcinoma: An International Multi-institutional Analysis of 1146 Patients. 
  • A Novel Classification of Intrahepatic Cholangiocarcinoma Phenotypes Using Machine Learning Techniques: An International Multi-Institutional Analysis. 
  • A case of curative-intent hepatectomy for colon cancer metastatic to the scapula and liver. 
  • A literature-based treatment algorithm for low-grade neuroendocrine liver metastases. 
  • A perioperative multidisciplinary care bundle reduces surgical site infections in patients undergoing synchronous colorectal and liver resection. 
  • A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903. 
  • A preoperative prognostic model to predict surgical success in patients with perihilar cholangiocarcinoma. 
  • A segmental approach to computerized tomographic portography for hepatic resection. 
  • A simplified single stage total hepatectomy in the rat with maintenance of gastrointestinal absorptive function. 
  • A standard definition of major hepatectomy: resection of four or more liver segments. 
  • A20 protects mice from lethal liver ischemia/reperfusion injury by increasing peroxisome proliferator-activated receptor-alpha expression. 
  • A20 protects mice from lethal radical hepatectomy by promoting hepatocyte proliferation via a p21waf1-dependent mechanism. 
  • AGA Technical Review on Systemic Therapies for Hepatocellular Carcinoma. 
  • ALPPS Procedure for Hepatocellular Carcinoma in Patients With Chronic Liver Disease: Revealing a Terra Incognita. 
  • ASO Visual Abstract: Tumor Burden Dictates Prognosis Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma: A Tool to Guide Post-Resection Adjuvant Chemotherapy? 
  • Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment. 
  • Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma. 
  • Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure? 
  • Acute kidney injury after cardiac and non-cardiac surgery: are there more similarities than differences? 
  • Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases. 
  • Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients. 
  • Adjuvant chemotherapy for colorectal hepatic metastases: role of route of administration and timing. 
  • Alpha 1-adrenergic effects and liver regeneration. 
  • Anatomic versus non-anatomic resection for hepatocellular carcinoma: A systematic review and meta-analysis. 
  • Anesthetic management of a patient having a carcinoid syndrome. 
  • Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. 
  • Antifibrinolytic use during cardiac and hepatic surgery makes tubular proteinuria-based early biomarkers poor tools to diagnose perioperative acute kidney injury. 
  • Assessing Textbook Outcomes Following Liver Surgery for Primary Liver Cancer Over a 12-Year Time Period at Major Hepatobiliary Centers. 
  • Assessing post-discharge costs of hepatopancreatic surgery: an evaluation of Medicare expenditure. 
  • Associating liver partition and portal vein ligation for staged hepatectomy in patients with primary liver malignancies: A systematic review of the literature. 
  • Association of Hospital Market Concentration With Costs of Complex Hepatopancreaticobiliary Surgery. 
  • Bile acid transport in the anhepatic rat. 
  • Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: incidence, clinical features, and risk factors. 
  • CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases. 
  • Case 23-2005: a man with a mass in the liver. 
  • Case report. Intrabiliary colonic metastasis mimicking primary biliary neoplasia. 
  • Central hepatectomy versus extended hepatectomy for liver malignancy: a matched cohort comparison. 
  • Characterization of 57 kDa statin as a true marker for growth arrest in tissue by its disappearance from regenerating liver. 
  • Chemotherapy-induced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorectal cancer. 
  • Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence. 
  • Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection. 
  • Colorectal cancer with potentially resectable hepatic metastases: optimizing treatment. 
  • Combined ablation and resection (CARe) as an effective parenchymal sparing treatment for extensive colorectal liver metastases. 
  • Comment on: Major hepatectomy with or without pancreatoduodenectomy for advanced gallbladder cancer. 
  • Comparison between liver transplantation and resection for hilar cholangiocarcinoma: A systematic review and meta-analysis. 
  • Comparison between perioperative and postoperative chemotherapy after potentially curative hepatic resection for metastatic colorectal cancer. 
  • Comparison between robotic and open liver resection: a systematic review and meta-analysis of short-term outcomes. 
  • Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer. 
  • Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer. 
  • Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma. 
  • Contralateral inflow occlusion to optimize graft volume and to reduce blood loss during parenchymal dissection in living-related liver transplantation. 
  • Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution. 
  • Current Approaches in the Management of Hepatic Adenomas. 
  • Current status of hepatic resection. 
  • Cytoablative therapy with combined resection and cryosurgery for limited bilobar hepatic colorectal metastases. 
  • Cytokine regulation of liver injury and repair. 
  • Deep Learning Algorithm for Automated Segmentation and Volume Measurement of the Liver and Spleen Using Portal Venous Phase Computed Tomography Images. 
  • Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients. 
  • Detailed pathologic characteristics of the primary colorectal tumor independently predict outcome after hepatectomy for metastases. 
  • Development and Validation of a Laboratory Risk Score (LabScore) to Predict Outcomes after Resection for Intrahepatic Cholangiocarcinoma. 
  • Diaphragmatic Hernias after Living Donor Hepatectomy: A Critical Reappraisal. 
  • Differential expression of guanine nucleotide-binding proteins enhances cAMP synthesis in regenerating rat liver. 
  • Differential regulation of hepatocyte DNA synthesis by cAMP in vitro in vivo. 
  • Does the presence of coronary artery disease impact perioperative outcomes following partial hepatectomy? 
  • Early liver metastases after "failure" of adjuvant chemotherapy for stage III colorectal cancer: is there a role for additional adjuvant therapy? 
  • Early trends in serum phosphate and creatinine levels are associated with mortality following major hepatectomy. 
  • Effect of Surgical Margin Width on Patterns of Recurrence among Patients Undergoing R0 Hepatectomy for T1 Hepatocellular Carcinoma: An International Multi-Institutional Analysis. 
  • Effect of actinomycin D on serum betalipoproteins of partially hepatectomized dogs. I. Proteins, lipids, triglycerides and cholesterol. 
  • Effect of actinomycin D on serum betalipoproteins of partially hepatectomized dogs. II - Phospholipids. 
  • Effect of actinomycin D on serum betalipoproteins of partially hepatectomized dogs. III - Fatty acid distribution. 
  • Effect of epidural compared to patient-controlled intravenous analgesia on outcomes for patients undergoing liver resection for neoplastic disease. 
  • Effect of ethanol on polyamine synthesis during liver regeneration in rats. 
  • Effects of chronic ethanol consumption on cytokine regulation of liver regeneration. 
  • Effects of terlipressin versus splenectomy on liver regeneration after partial hepatectomy in rats: What we know so far? 
  • Elevated intrahepatic pressures and decreased hepatic tissue blood flow prevent gas embolus during limited laparoscopic liver resections. 
  • Epidural analgesia in hepatic resection. 
  • Ethanol induces redox-sensitive cell-cycle inhibitors and inhibits liver regeneration after partial hepatectomy. 
  • Ethanol interferes with regeneration-associated changes in biotransforming enzymes: a potential mechanism underlying ethanol's carcinogenicity? 
  • Evolution of surgical management of gallbladder carcinoma and impact on outcome: results from two decades at a single-institution. 
  • Examining reoperation and readmission after hepatic surgery. 
  • Experience with more than 500 minimally invasive hepatic procedures. 
  • Extended hepatectomy using the bipolar tissue sealer: an experimental model of small-for-size syndrome in pigs. 
  • Extended hepatic resection for gallbladder cancer. 
  • Fibronectin Extra Domain A Promotes Liver Sinusoid Repair following Hepatectomy. 
  • Frailty as a Risk Predictor of Morbidity and Mortality Following Liver Surgery. 
  • From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. 
  • Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. 
  • Gene expression profiles accurately predict outcome following liver resection in patients with metastatic colorectal cancer. 
  • Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases. 
  • Goal-Directed Fluid Therapy Using Stroke Volume Variation for Resuscitation after Low Central Venous Pressure-Assisted Liver Resection: A Randomized Clinical Trial. 
  • Hedgehog regulates yes-associated protein 1 in regenerating mouse liver. 
  • Hedgehog signaling is critical for normal liver regeneration after partial hepatectomy in mice. 
  • Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis: A Case-control Study With Comparison to Medically Treated Patients. 
  • Hepatic and pancreatic resection in patients with end-stage renal disease: a propensity analysis. 
  • Hepatic micrometastases are associated with poor prognosis in patients with liver metastases from neuroendocrine tumors of the digestive tract. 
  • Hepatic parenchymal preservation surgery: decreasing morbidity and mortality rates in 4,152 resections for malignancy. 
  • Hepatic parenchymal transection with vascular staplers: a comparative analysis with the crush-clamp technique. 
  • Hepatic pedicle clamping during hepatic resection for colorectal liver metastases: no impact on survival or hepatic recurrence. 
  • Hepatic resection for hepatocellular carcinoma: do contemporary morbidity and mortality rates demand a transition to ablation as first-line treatment? 
  • Hepatic resection for metastatic cancer. 
  • Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era. 
  • Hepatocellular carcinoma in patients with no identifiable risk factors. 
  • Hepatocellular carcinoma: clinical and angiographic findings and predictability for surgical resection. 
  • Hepatocellular expression of glucose-6-phosphatase is unaltered during hepatic regeneration. 
  • Heterogeneity of management practices surrounding operable gallbladder cancer - results of the OMEGA-S international HPB surgical survey. 
  • Histopathological growth patterns and positive margins after resection of colorectal liver metastases. 
  • Histopathological prognostic factors influencing long-term prognosis after surgical resection for hepatic metastases from colorectal cancer. 
  • Hospital readmissions after liver surgery for metastatic colorectal cancer. 
  • Hypophosphatemia after Hepatectomy or Pancreatectomy: Role of the Nicotinamide Phosphoribosyltransferase. 
  • Hypophosphatemia in a pediatric patient after major hepatic resection. 
  • Hypoxia of the growing liver accelerates regeneration. 
  • Identification of patients at high risk for post-discharge venous thromboembolism after hepato-pancreato-biliary surgery: which patients benefit from extended thromboprophylaxis? 
  • Imaging findings of liver resection using a bipolar radiofrequency electrosurgical device--initial observations. 
  • Impact of Primary Tumor Laterality on Adjuvant Hepatic Artery Infusion Pump Chemotherapy in Resected Colon Cancer Liver Metastases: Analysis of 487 Patients. 
  • Impact of cancer center accreditation on outcomes of patients undergoing resection for hepatocellular carcinoma: A SEER-Medicare analysis. 
  • Impact of simultaneous diaphragm resection during hepatectomy for treatment of metastatic colorectal cancer. 
  • Impact of steatosis on perioperative outcome following hepatic resection. 
  • Impact of time-to-surgery on outcomes of patients undergoing curative-intent liver resection for BCLC-0, A and B hepatocellular carcinoma. 
  • Improved survival and higher rates of surgical resection associated with hepatocellular carcinoma in children as compared to young adults. 
  • Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases. 
  • Integration of a dedicated management protocol in the care of pediatric liver cancer: From specialized providers to complication reduction. 
  • Inter-surgeon variability is associated with likelihood to undergo minimally invasive hepatectomy and postoperative mortality. 
  • Intrahepatic tumor recurrence after partial hepatectomy: value of percutaneous radiofrequency ablation. 
  • Intrahepatic, extramedullary hematopoiesis mimicking hemangioma on technetium-99m red blood cell SPECT examination. 
  • Invasive central venous monitoring during hepatic resection: unnecessary for most patients. 
  • Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients. 
  • Is minimally invasive surgery of lesions in the right superior segments of the liver justified? A multi-institutional study of 245 patients. 
  • Is resident assistance equivalent to fellows during hepatectomy? 
  • Is there a role for simultaneous hepatic and colorectal resections? A contemporary view from NSQIP. 
  • KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases. 
  • Kupffer cell depletion abolishes induction of interleukin-10 and permits sustained overexpression of tumor necrosis factor alpha messenger RNA in the regenerating rat liver. 
  • Kupffer cell depletion by CI2MDP-liposomes alters hepatic cytokine expression and delays liver regeneration after partial hepatectomy. 
  • Kupffer cell depletion by gadolinium chloride enhances liver regeneration after partial hepatectomy in rats. 
  • Laparoscopic Hepatectomy for Hepatocellular Carcinoma: The Opportunities, the Challenges, and the Limitations. 
  • Laparoscopic liver surgery: a synopsis. 
  • Laparoscopic major hepatectomy: an evolution in standard of care. 
  • Laparoscopic synchronous resection of colorectal cancer and liver metastases: A systematic review. 
  • Laparoscopic versus open liver resection: a matched-pair case control study. 
  • Laparoscopic versus robotic major hepatectomy: a systematic review and meta-analysis. 
  • Laparoscopic vs open right hepatectomy: a value-based analysis. 
  • Left hepatic trisectionectomy for hepatobiliary malignancy: results and an appraisal of its current role. 
  • Less is more: salvageability as the new creed in surgery of colorectal liver metastatic disease. 
  • Liver regeneration 3: Regulation of signal transduction during liver regeneration. 
  • Liver resection for metastatic melanoma with postoperative tumor-infiltrating lymphocyte therapy. 
  • Liver transplantation for unresectable colorectal liver metastases. 
  • Liver transplantation for unresectable colorectal liver metastases: A systematic review. 
  • Liver transplantation. Initiation of the first program in North Carolina. 
  • Liver-specific loss of beta-catenin results in delayed hepatocyte proliferation after partial hepatectomy. 
  • Living related donor liver transplantation at the University of Nebraska Medical Center (1996). 
  • Long-term ethanol consumption alters the hepatic response to the regenerative effects of tumor necrosis factor-alpha. 
  • Long-term follow-up of auxiliary liver transplantation for fulminant hepatic failure. 
  • Long-term follow-up of auxiliary orthotopic liver transplantation for the treatment of fulminant hepatic failure. 
  • Long-term oncologic outcomes for simultaneous resection of synchronous metastatic liver and primary colorectal cancer. 
  • Long-term survival after spontaneous rupture of a malignant rhabdoid tumor of the liver. 
  • Major liver resection in elderly patients: a multi-institutional analysis. 
  • Management of advanced neuroendocrine tumors with hepatic metastasis. 
  • Management of hepatocellular adenoma: comparison of resection, embolization and observation. 
  • Management strategies for patients with advanced rectal cancer and liver metastases using modified Delphi methodology: results from the PelvEx Collaborative. 
  • Management, outcomes, and prognostic factors of ruptured hepatocellular carcinoma: A systematic review. 
  • Mechanistic insights of rapid liver regeneration after associating liver partition and portal vein ligation for stage hepatectomy. 
  • Minimally invasive liver resection for metastatic colorectal cancer: a multi-institutional, international report of safety, feasibility, and early outcomes. 
  • Multi-institutional analysis of recurrence and survival after hepatectomy for fibrolamellar carcinoma. 
  • Multiagent chemotherapy for isolated colorectal liver metastases: a single-centered retrospective study. 
  • Myofibroblastic cells function as progenitors to regenerate murine livers after partial hepatectomy. 
  • Mystery of Liver Regeneration After Portal Flow Changes: The Inductive Way of Thinking May Give the Answers. 
  • Natural history of patients with subcentimeter pulmonary nodules undergoing hepatic resection for metastatic colorectal cancer. 
  • Nodular regenerative hyperplasia in partial hepatectomy specimens. 
  • Non-Hodgkin lymphoma presenting with obstructive jaundice. 
  • Operative Results and Oncologic Outcomes of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Versus Two-Stage Hepatectomy (TSH) in Patients with Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-Analysis. 
  • Operative morbidity and survival following hepatectomy for colorectal liver metastasis in octogenarians: a contemporary case matched series. 
  • Orthotopic liver transplant patients require less postoperative morphine than do patients undergoing hepatic resection. 
  • Outcomes after Resection of Intrahepatic Cholangiocarcinoma: External Validation and Comparison of Prognostic Models. 
  • Overall Tumor Burden Dictates Outcomes for Patients Undergoing Resection of Multinodular Hepatocellular Carcinoma Beyond the Milan Criteria. 
  • Pancreas and liver resection in Jehovah's Witness patients: feasible and safe. 
  • Parenchymal-Sparing Versus Anatomic Liver Resection for Colorectal Liver Metastases: a Systematic Review. 
  • Parenchymal-sparing Hepatectomy as the New Doctrine in the Treatment of Liver-metastatic Colorectal Disease: Beyond Oncological Outcomes. 
  • Partial hepatectomy and bile duct ligation in rainbow trout (Oncorhynchus mykiss): histologic, immunohistochemical and enzyme histochemical characterization of hepatic regeneration and biliary hyperplasia. 
  • Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome. 
  • Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. 
  • Patient Triage for Resection of Metastatic Colorectal Cancer to the Liver: Can We Do Better Using MRI? 
  • Patterns of recurrence after ablation of colorectal cancer liver metastases. 
  • Percutaneous Hepaticojejunostomy across an Isolated Bile Duct after Klatskin Tumor Resection. 
  • Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy. 
  • Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases. 
  • Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer. 
  • Personalized treatment in patients with colorectal liver metastases. 
  • Pharmacologic prophylaxis, postoperative INR, and risk of venous thromboembolism after hepatectomy. 
  • Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes. 
  • Positive postoperative CEA is a strong predictor of recurrence for patients after resection for colorectal liver metastases. 
  • Post-operative pharmacologic thromboprophylaxis after major hepatectomy: does peripheral venous thromboembolism prevention outweigh bleeding risks? 
  • Postoperative Liver Failure Risk Score: Identifying Patients with Resectable Perihilar Cholangiocarcinoma Who Can Benefit from Portal Vein Embolization. 
  • Postoperative Mortality after Liver Resection for Perihilar Cholangiocarcinoma: Development of a Risk Score and Importance of Biliary Drainage of the Future Liver Remnant. 
  • Predicting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma. 
  • Predicting recurrence patterns after resection of hepatocellular cancer. 
  • Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases. 
  • Predictive indices of morbidity and mortality after liver resection. 
  • Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience. 
  • Preoperative estimation in living related donor transplantation: clinical correlation and donor/recipient ratio. 
  • Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification. 
  • Prognostic significance of early recurrence: a conditional survival analysis in patients with resected colorectal liver metastasis. 
  • Prognostic significance of primary tumor sidedness in patients undergoing liver resection for metastatic colorectal cancer. 
  • Prognostic utility of albumin-bilirubin grade for short- and long-term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: A multi-institutional analysis of 706 patients. 
  • Prometheus revisited. 
  • Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. 
  • Quantitative Imaging Features and Postoperative Hepatic Insufficiency: A Multi-Institutional Expanded Cohort. 
  • Rapid tracking of small displacements with ultrasound 
  • Recurrence After Partial Hepatectomy for Metastatic Colorectal Cancer: Potentially Curative Role of Salvage Repeat Resection. 
  • Recurrence Patterns and Disease-Free Survival after Resection of Intrahepatic Cholangiocarcinoma: Preoperative and Postoperative Prognostic Models. 
  • Recurrence Patterns and Outcomes after Resection of Hepatocellular Carcinoma within and beyond the Barcelona Clinic Liver Cancer Criteria. 
  • Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection. 
  • Recurrent tumor after resection of hepatic metastases from colorectal carcinoma: location and time of discovery as determined by CT. 
  • Regeneration of a transplanted liver after right hepatic lobectomy. 
  • Regenerative hepatic pseudotumor: a new pseudotumor of the liver. 
  • Regionalization of hepatic resections is associated with increasing disparities among some patient populations in use of high-volume providers. 
  • Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure. 
  • Renal function after low central venous pressure-assisted liver resection: assessment of 2116 cases. 
  • Renal outcomes following left renal vein harvest for venous reconstruction during pancreas and liver surgery. 
  • Rescue of a living donor with liver transplantation. 
  • Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate? 
  • Resection of adrenocortical carcinoma liver metastasis: is it justified? 
  • Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis. 
  • Risk of occult irresectable disease at liver resection for hepatic colorectal cancer metastases: a contemporary analysis. 
  • Robotic Liver Resection: A Case-Matched Comparison. 
  • Routine Intensive Care Unit Admission Following Liver Resection: What Is the Value Proposition? 
  • STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers. 
  • Safety and oncologic outcomes of robotic liver resections: A systematic review. 
  • Short-Term Risk of Performing Concurrent Procedures with Hepatic Artery Infusion Pump Placement. 
  • Simultaneous diaphragm and liver resection: a propensity-matched analysis of postoperative morbidity. 
  • Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure. 
  • Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. 
  • Single-incision laparoscopic liver resection. 
  • Supplemental putrescine reverses ethanol-associated inhibition of liver regeneration. 
  • Suprahepatic venacavaplasty (cavaplasty) with retrohepatic cava extension in liver transplantation: experience with first 115 cases. 
  • Surgical clearance for the patient with chronic liver disease. 
  • Surgical resection for benign and malignant liver disease. 
  • Surgical resection for small hepatocellular carcinoma. 
  • Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. 
  • Symptomatic Perihepatic Fluid Collections After Hepatic Resection in the Modern Era. 
  • Synchronous Hemihepatectomy With Pancreatectomy Through Application of Associated Liver Partition and Portal Vein Ligation for a Metastatic Gastrinoma. 
  • Synchronous colorectal liver metastases: the "surgeon as oncologist" perspective. 
  • Synchronous resection of esophageal cancer and other organ malignancies: A systematic review. 
  • Synchronous resection of primary and liver metastases for neuroendocrine tumors. 
  • TWEAK/Fn14 signaling is required for liver regeneration after partial hepatectomy in mice. 
  • Technical modifications and outcomes after Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) for primary liver malignancies: A systematic review. 
  • Texture analysis of preoperative CT images for prediction of postoperative hepatic insufficiency: a preliminary study. 
  • The ALPPS procedure as a novel "liver-first" approach in treating liver metastases of colon cancer: the first experience in Greek Cypriot area. 
  • The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. 
  • The Effect of Frailty Index on Early Outcomes after Combined Colorectal and Liver Resections. 
  • The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer. 
  • The accuracy of pre-operative imaging in the management of hepatic cysts. 
  • The approach to the patient with single and multiple liver metastases, pulmonary metastases, and intra-abdominal metastases from colorectal carcinoma. 
  • The clinical implications of hypophosphatemia following major hepatic resection or cryosurgery. 
  • The current status of living donor liver transplantation. 
  • The effect of Guidelines in surgical decision making: The paradigm of hepatocellular carcinoma. 
  • The ideal porcine model for major liver resection. 
  • The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases. 
  • The potential role of preoperative portal vein embolization for the prevention of small-for-size syndrome. 
  • The relationship of hospital market concentration, costs, and quality for major surgical procedures. 
  • Time-to-Surgery and Survival Outcomes in Resectable Colorectal Liver Metastases: A Multi-Institutional Evaluation. 
  • Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis. 
  • Transplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait times. 
  • Transport of free fatty acid and triglyceride in anhepatic rats. 
  • Transverse hepatectomy for symptomatic polycystic liver disease. 
  • Travel distance and overall survival in hepatocellular cancer care. 
  • Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease. 
  • Trends and outcomes of simultaneous versus staged resection of synchronous colorectal cancer and colorectal liver metastases. 
  • Tumor Burden Dictates Prognosis Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma: A Tool to Guide Post-Resection Adjuvant Chemotherapy? 
  • Tumor MHC class I expression improves the prognostic value of T-cell density in resected colorectal liver metastases. 
  • Tumor necrosis factor-alpha induces c-jun during the regenerative response to liver injury. 
  • Update on Surgical Management of Small Bowel Neuroendocrine Tumors. 
  • Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy. 
  • Updates and Critical Insights on Glissonian Approach in Liver Surgery. 
  • Use of bioluminescence imaging to detect enhanced hepatic and systemic tumor growth following partial hepatectomy in mice. 
  • Use of intraoperative ablation as an adjunct to surgical resection in the treatment of recurrent colorectal liver metastases. 
  • Utility of Image Guidance in the Localization of Disappearing Colorectal Liver Metastases. 
  • Utility of Serum Inflammatory Markers for Predicting Microvascular Invasion and Survival for Patients with Hepatocellular Carcinoma. 
  • Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines. 
  • Vascular inflow control during hemi-hepatectomy: a comparison between intrahepatic pedicle ligation and extrahepatic vascular ligation. 
  • Venous thromboembolism after hepatic resection: analysis of 5,706 patients. 
  • Venovenous bypass in adult orthotopic liver transplantation: routine or selective use? 
  • Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma: Considering Alternative Treatment Approaches. 
  • We've come a long way, baby! 
  • Wound classification reporting in HPB surgery: can a single word change public perception of institutional performance? 
• 

  Keywords of People

  • Choi, Steven Sok, Associate Professor of Medicine, Medicine, Gastroenterology
  • Knechtle, Stuart Johnston, William R. Kenan, Jr. Distinguished Professor, Medicine, Nephrology